期刊的影响因子--文章列表

期刊文章列表
Zhiqiang Hu，Zongchao Liu，Wenqing Li，Weicheng You，Kaifeng Pan（State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers,Beijing Key Laboratory of Carcinogenesis and Translational Research,Department of Cancer Epidemiology,Peking University Cancer Hospital & Institute；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Cancer Epidemiology,Peking University Cancer Hospital & Institute）.Health economic evaluation on population-based Helicobacter pylori eradication and endoscopic screening for gastric cancer prevention[J].Chinese Journal of Cancer Research,2023,第6期 Zhouting Tuo，Dechao Feng，Zhiwei Jiang，Liangkuan Bi，Chao Yang，Qi Wang（Department of Urology,the Second Affiliated Hospital of Anhui Medical University；Department of Urology,Institute of Urology,West China Hospital,Sichuan University；Department of Rehabilitation,the Affiliated Hospital of Southwest Medical University；Department of Urology,Peking University Shenzhen Hospital）.Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis[J].Chinese Journal of Cancer Research,2023,第6期 Yinan Zhang，Hongtao Zhang，Yan Yan，Ke Ji，Ziyu Jia，Heli Yang，Biao Fan，Anqiang Wang，Xiaojiang Wu，Ji Zhang，Jiafu Ji，Xin Ji，Zhaode Bu（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital & Institute；Guowen (Changchun) International Hospital；State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers,Beijing Key Laboratory of Carcinogenesis and Translational Research,Endoscopy Center,Peking University Cancer Hospital & Institute；State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers,Beijing Key Laboratory of Carcinogenesis and Translational Research,Gastrointestinal Cancer Center,Peking University Cancer Hospital & Institute）.Double-tract reconstruction is superior to esophagogastrostomy in controlling reflux esophagitis and enhancing quality of life after proximal gastrectomy: Results from a prospective randomized controlled clinical trial in China[J].Chinese Journal of Cancer Research,2023,第6期 Sung Gon Kim，Sang Eok Lee，Bang Wool Eom，Hong Man Yoon，Young-Woo Kim，Keun Won Ryu（Department of Surgery,Konyang University Hospital；Center for Gastric Cancer,Research Institute & Hospital,National Cancer Center）.Gastric cancer surgery in South Korea: Past,present,and future[J].Chinese Journal of Cancer Research,2023,第6期 Hangcheng Xu，Binghe Xu（Department of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College）.Breast cancer: Epidemiology,risk factors and screening[J].Chinese Journal of Cancer Research,2023,第6期 Hao Chen，Xuelian Zhao，Shangying Hu，Tingting You，Changfa Xia，Meng Gao，Mingjie Dong，Youlin Qiao，Fanghui Zhao（Department of Cancer Epidemiology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Office of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；School of Population Medicine and Public Health,Chinese Academy of Medical Sciences and Peking Union Medical College；Center for Global Health,School of Population Medicine and Public Health,Chinese Academy of Medical Sciences and Peking Union Medical College）.Estimation of economic burden throughout course of cervical squamous intraepithelial lesion and cervical cancer in China:A nationwide multicenter cross-sectional study[J].Chinese Journal of Cancer Research,2023,第6期 Ruixin Yang，Zhen Xiang，Ranlin Yan，Wingyan Kwan，Lu Zang，Zhenggang Zhu，Yao Qi，Yanping Xu，Xiaoyan Zhang，Hengjun Gao，Yingyan Yu（Department of General Surgery of Ruijin Hospital,Shanghai Institute of Digestive Surgery,and Shanghai Key Laboratory for Gastric Neoplasms,Shanghai Jiao Tong University School of Medicine；Shanghai Engineering Center for Molecular Medicine）.Benchmark for establishment of organoids from gastrointestinal epithelium and cancer based on available consumables and reagents[J].Chinese Journal of Cancer Research,2023,第6期 Hongyu Xiang，Ling Xin，Jingming Ye，Ling Xu，Hong Zhang，Shuang Zhang，Yinhua Liu（Department of Thyroid and Breast Surgery,Peking University First Hospital；Department of Pathology,Peking University First Hospital）.A multicenter study on efficacy of dual-target neoadjuvant therapy for HER2-positive breast cancer and a consistent analysis of efficacy evaluation of neoadjuvant therapy by Miller-Payne and RCB pathological evaluation systems(CSBrS-026)[J].Chinese Journal of Cancer Research,2023,第6期 Yi Teng，Changfa Xia，Maomao Cao，Fan Yang，Xinxin Yan，Siyi He，Mengdi Cao，Shaoli Zhang，Qianru Li，Nuopei Tan，Jiachen Wang，Wanqing Chen（Office of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College）.Lung cancer burden and trends from 2000 to 2018 in China:Comparison between China and the United States[J].Chinese Journal of Cancer Research,2023,第6期 Zhonghu He，Yang Ke（State Key Laboratory of Molecular Oncology,Beijing Key Laboratory of Carcinogenesis and Translational Research,Department of Genetics,Peking University Cancer Hospital & Institute）.Challenge and future of cancer screening in China: Insights from esophageal cancer screening practice[J].Chinese Journal of Cancer Research,2023,第6期 Yong Yang，Zhaoya Gao，An Huang，Jingyi Shi，Zhuang Sun，Haopeng Hong，Jin Gu（Department of Gastrointestinal Surgery,Peking University Shougang Hospital；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital & Institute）.Epidemiology and early screening strategies for colorectal cancer in China[J].Chinese Journal of Cancer Research,2023,第6期 Shin-Hoo Park，Ye-Rim Shin，Hoon Hur，Chang Min Lee，Jae Seok Min，Seung Wan Ryu，Hyun Dong Chae，Oh Jeong，Chang-In Choi，Kyo-Young Song，Ho Goon Kim，Ye Seob Jee，Kwang Hee Kim，Jeong Goo Kim，Kyung Sook Yang，Hua Huang，Sungsoo Park（Division of Foregut Surgery,Korea University College of Medicine；Division of Foregut Surgery,Korea University Anam Hospital；Department of Surgery,Ajou University School of Medicine；Division of Foregut Surgery,Korea University Ansan Hospital；Department of Surgery,Dongnam Institute of Radiological and Medical Sciences,Cancer Center；Department of Surgery,Keimyung University Dongsan Medical Center；Department of Surgery,Catholic University of Daegu School of Medicine；Department of Surgery,Chonnam National University Medical School；Department of Surgery,Pusan National University Hospital；Department of Surgery,Catholic University of Seoul St Mary’s Hospital；Department of Surgery,Dankook University College of Medicine；Department of Surgery,Busan Paik Hospital,Inje University；Department of Surgery,Daejeon St.Mary’s Hospital,College of Medicine,the Catholic University of Korea；Department of Biostatistics,Korea University College of Medicine；Department of Gastric Cancer and Soft Tissue Sarcoma,Fudan University Shanghai Cancer Center；Department of Oncology,Shanghai Medical College,Fudan University）.Exploring ideal operative time for best outcomes in gastric cancer surgery: A multi-institutional study based on KLASS-07 database[J].Chinese Journal of Cancer Research,2023,第6期 Binghe Xu，Hangcheng Xu（Department of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College）.Preface to Special Issue: Cancer epidemiology,risk factors and screening[J].Chinese Journal of Cancer Research,2023,第6期 Jing Zhang¹，Haohua Yao，Chunliu Lai¹，Xue Sun，Xiujuan Yang⁴，Shurong Li⁵，Yubiao Guo¹，Junhang Luo⁶，Zhihua Wen⁵，Kejing Tang^1,7（Division of Pulmonary and Critical Care Medicine,the First Affiliated Hospital of Sun Yat-sen University；Department of Urology,Guangdong Provincial People’s Hospital,Guangdong Academy of Medical Sciences；Department of Respiratory and Critical Care Medicine,the Fourth People’s Hospital of Shenyang；Department of Pharmacy,Zhujiang Hospital,Southern Medical University；Department of Radiology,the First Affiliated Hospital of Sun Yat-sen University；Department of Urology,the First Affiliated Hospital of Sun Yat-sen University；Department of Pharmacy,the First Affiliated Hospital of Sun Yat-Sen University）.A novel multimodal prediction model based on DNA methylation biomarkers and low-dose computed tomography images for identifying early-stage lung cancer[J].Chinese Journal of Cancer Research,2023,第5期 Yijing Zhao，Hanfei Guo^2,3，Yingjun Chang（Peking University People’s Hospital,Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation；Stanford University Medical School,VA Palo Alto Health Care System；First Hospital of Jilin University,Cancer Center）.MRD-directed and risk-adapted individualized stratified treatment of AML[J].Chinese Journal of Cancer Research,2023,第5期 Shuping Cheng¹，Butuo Li¹，Jinming Yu^2,3，Linlin Wang^2,3（Department of Radiation Oncology,Shandong Cancer Hospital Affiliated to Shandong First Medical University；Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences；Research Unit of Radiation Oncology,Chinese Academy of Medical Sciences）.Update of latest data for combined therapy for esophageal cancer using radiotherapy and immunotherapy: A focus on efficacy,safety,and biomarkers[J].Chinese Journal of Cancer Research,2023,第5期 Yunfei Shi¹，Haojie Wang²，Yanfei Liu³，Mengping Long¹，Ning Ding³，Lan Mi³，Yumei Lai¹，Lixin Zhou¹，Xinting Diao¹，Xianghong Li¹，Weiping Liu³，Jun Zhu³（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Pathology,Peking University Cancer Hospital &Institute；Institute of Genetics and Developmental Biology,Chinese Academy of Sciences；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Lymphoma,Peking University Cancer Hospital &Institute）.Genetic abnormalities assist in pathological diagnosis and EBVpositive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients[J].Chinese Journal of Cancer Research,2023,第5期 Wenhao Luo，Jun Wang，Hao Chen，Liyuan Ye，Jiangdong Qiu，Yueze Liu，Ruobing Wang，Guihu Weng，Tao Liu，Dan Su，Jinxin Tao，Chen Ding，Lei You，Taiping Zhang（Department of General Surgery,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College）.Epidemiology of pancreatic cancer: New version,new vision[J].Chinese Journal of Cancer Research,2023,第5期 Zhi Li¹，Liming Lu¹，Yibin Deng²，Amei Zhuo¹，Fengling Hu¹，Wanwen Sun¹，Guitian Huang，Linyuan Liu¹，Boqi Rao¹，Jiachun Lu¹，Lei Yang¹（The State Key Lab of Respiratory Disease,Institute of Public Health,Guangzhou Medical University；Center for Medical Laboratory Science,the Affiliated Hospital of Youjiang Medical University for Nationalities；Physical examination center,Guangzhou First People’s Hospital）.Genetic susceptibility loci of lung cancer are associated with malignant risk of pulmonary nodules and improve malignancy diagnosis based on CEA levels[J].Chinese Journal of Cancer Research,2023,第5期 Hayun Kim¹，Sungsoo Park^2,3,4（Department of Medicine,Korea University College of Medicine；Division of Foregut Surgery, Korea University College of Medicine; Center for Obesity and Metabolic Diseases, Korea University Anam Hospital; Gut & Metabolism Laboratory, Korea University College of Medicine）.Advances,breakthroughs,and challenges in gastric cancer surgery[J].Chinese Journal of Cancer Research,2023,第5期 Qingrong Sun^1,2,3，Qingqing Xu¹，Majie Wang⁴，Yongcheng Wang²，Dandan Zhang^1,3，Maode Lai^1,3,5（Department of Pathology and Key Laboratory of Disease Proteomics of Zhejiang Province,Zhejiang University School of Medicine；Liangzhu Laboratory,Zhejiang University Medical Center；Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare；Ningbo Kangning Hospital,Key Laboratory of Addiction Research of Zhejiang Province；Department of Basic Medicine,School of Basic Medicine and Clinical Pharmacy,China Pharmaceutical University）.OpenNAU: An open-source platform for normalizing,analyzing,and visualizing cancer untargeted metabolomics data[J].Chinese Journal of Cancer Research,2023,第5期 Yong Yang¹，Zhaoya Gao¹，Jin Gu^1,2（Department of Gastrointestinal Surgery,Peking University Shougang Hospital；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital &Institute）.Comments on National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China(English version)[J].Chinese Journal of Cancer Research,2023,第5期 Yang Liu¹，Ya-nan Ren¹，Yan Cui¹，Song Liu¹，Zhi Yang²，Hua Zhu²，Nan Li¹（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration),Department of Nuclear Medicine,Peking University Cancer Hospital &Institute；State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers,Beijing Key Laboratory of Carcinogenesis and Translational Research,NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration),Department of Nuclear Medicine,Peking University Cancer Hospital &Institute）.Inspired by novel radiopharmaceuticals: Rush hour of nuclear medicine[J].Chinese Journal of Cancer Research,2023,第5期 Jianwei Zhang¹，Haibin Zhu²，Lin Shen³，Jie Li¹，Xiaoyan Zhang²，Chunmei Bai⁴，Zhiwei Zhou⁵，Xianrui Yu⁶，Zhiping Li⁷，Enxiao Li⁸，Xianglin Yuan⁹，Wenhui Lou¹⁰，Yihebali Chi¹¹，Nong Xu¹²，Yongmei Yin¹³，Yuxian Bai¹⁴，Tao Zhang¹⁵，Dianrong Xiu¹⁶，Jia Chen¹⁷，Shukui Qin¹⁸，Xiuwen Wang¹⁹，Yujie Yang²⁰，Haoyun Shi²⁰，Xian Luo²⁰，Songhua Fan²⁰，Weiguo Su²⁰，Ming Lu³，Jianming Xu²¹（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Gastrointestinal Oncology,Peking University Cancer Hospital &Institute；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital &Institute；State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers,Beijing Key Laboratory of Carcinogenesis and Translational Research,Department of Gastrointestinal Oncology,Peking University Cancer Hospital &Institute；Department of Medical Oncology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Gastric Surgery,State Key Laboratory of Oncology in South China,Collaborative Innovation Centre for Cancer Medicine,Sun Yat-sen University Cancer Center；Department of Pancreatic and Hepatobiliary Surgery,Fudan University Shanghai Cancer Center；Department of Abdominal Oncology,West China Hospital,Sichuan University；Department of Medical Oncology,the First Affiliated Hospital of Xi’an Jiaotong University；Department of Oncology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology；Department of General Surgery,Zhongshan Hospital of Fudan University；Department of Medical Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Medical Oncology,the First Affiliated Hospital of Zhejiang University；Department of Medical Oncology,the First Affiliated Hospital of Nanjing Medical University；Department of Gastrointestinal Oncology,Harbin Medical University Cancer Hospital；Department of Oncology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology；Department of General Surgery,Peking University Third Hospital；Department of Medical Oncology,Jiangsu Cancer Hospital；Cancer Center of Jinling Hospital,Nanjing University of Chinese Medic）.Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib[J].Chinese Journal of Cancer Research,2023,第5期 Amber Xinyu Li¹，Jimmy Jianyuan Zeng¹，Tracey A Martin¹，Lin Ye¹，Fiona Ruge¹，Andrew J Sanders^1,2，Elyas Khan³，Q.Ping Dou^1,3，Eleri Davies⁴，Wen G Jiang¹（Cardiff China Medical Research Collaborative,Division of Cancer and Genetics,Cardiff University School of Medicine,Heath Park；School of Natural and Social Science,University of Gloucestershire,Francis Close Hall；Karmanos Cancer Institute,Department of Oncology,School of Medicine,Wayne State University；Wales Breast Center,Cardiff and Vales University Health Board,University Llandough Hospital）.Striatins and STRIPAK complex partners in clinical outcomes of patients with breast cancer and responses to drug treatment[J].Chinese Journal of Cancer Research,2023,第4期 Dechao Feng^1,2，Dengxiong Li¹，Yuhan Xiao¹，Ruicheng Wu¹，Jie Wang¹，Chi Zhang²（Department of Urology,Institute of Urology,West China Hospital,Sichuan University；Department of Rehabilitation,the Affiliated Hospital of Southwest Medical University）.Focal ablation therapy presents promising results for selectively localized prostate cancer patients[J].Chinese Journal of Cancer Research,2023,第4期 Yuehong Chen¹，Zhijing Yang¹，Mingli Zhao¹，Chuanjin Xu¹，Yuxuan Zhu²，Huimin Zhang¹，Huilin Huang¹，Yanmei Peng¹，Yanfeng Hu¹，Tian Lin¹，Tao Chen¹，Hao Chen¹，Liying Zhao¹，Hao Liu¹，Guoxin Li¹，Jiang Yu¹，Xinhua Chen¹（Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor,Nanfang Hospital,the First School of Clinical Medicine,Southern Medical University；The First Clinical Medical School,Southern Medical University）.Impact of preoperative therapy on surgical outcomes of laparoscopic total gastrectomy for gastric/gastroesophageal junction cancer[J].Chinese Journal of Cancer Research,2023,第4期 Hao Su，Zhaode Bu（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Center of Gastrointestinal Cancer,Peking University Cancer Hospital & Institute）.Research progress of minimally invasive surgery for gastric cancer[J].Chinese Journal of Cancer Research,2023,第4期首页 1 2 3 下一页尾页共有3页，转到页

期刊文章列表